PML and acute promyelocytic leukemia: Since the clinical RA administration was known to induce blast differentiation and complete remission in APL patients, PML was thereby classified as a tumor suppressor, and oncogenic regulation has since been considered an important function of PML-NBs [13,14,15,16].